ATE331734T1 - NEUROTROPHIC CILIAR FACTOR WITH ALTERED RANGE OF ACTIVITY COMPARED TO THE WILD-TYPE MOLECULE - Google Patents

NEUROTROPHIC CILIAR FACTOR WITH ALTERED RANGE OF ACTIVITY COMPARED TO THE WILD-TYPE MOLECULE

Info

Publication number
ATE331734T1
ATE331734T1 AT97932007T AT97932007T ATE331734T1 AT E331734 T1 ATE331734 T1 AT E331734T1 AT 97932007 T AT97932007 T AT 97932007T AT 97932007 T AT97932007 T AT 97932007T AT E331734 T1 ATE331734 T1 AT E331734T1
Authority
AT
Austria
Prior art keywords
factor
ciliar
neurotrophic
wild
activity compared
Prior art date
Application number
AT97932007T
Other languages
German (de)
Inventor
Ralph Laufer
Marco Annalise Di
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of ATE331734T1 publication Critical patent/ATE331734T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The variants of human ciliary neutrophic factor (hCNTF) according to the present invention are characterized by substitution of phenylalanine 152 and/or lysine 155 with alanine. These variants have biological properties that render them important as the active principles of drugs for the treatment of diseases and pathologies involving the nervous system or other pathologies involving cells responding to the CNTF. FIG. 2 shows the results of simulation of haptoglobin secretion from HepG2 cells by CNTF and the variants described in the invention.
AT97932007T 1996-07-10 1997-07-10 NEUROTROPHIC CILIAR FACTOR WITH ALTERED RANGE OF ACTIVITY COMPARED TO THE WILD-TYPE MOLECULE ATE331734T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000492A IT1284867B1 (en) 1996-07-10 1996-07-10 VARIATIONS OF THE HUMAN CHILIARY NEUROTROPHIC FACTOR (HCNTF) WITH A SPECTRUM OF ACTION DIFFERENT FROM THE WILD-TYPE MOLECULE

Publications (1)

Publication Number Publication Date
ATE331734T1 true ATE331734T1 (en) 2006-07-15

Family

ID=11404333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932007T ATE331734T1 (en) 1996-07-10 1997-07-10 NEUROTROPHIC CILIAR FACTOR WITH ALTERED RANGE OF ACTIVITY COMPARED TO THE WILD-TYPE MOLECULE

Country Status (11)

Country Link
US (1) US6756357B1 (en)
EP (1) EP0936919B1 (en)
JP (1) JP3329826B2 (en)
AT (1) ATE331734T1 (en)
AU (1) AU719086B2 (en)
CA (1) CA2260296C (en)
DE (1) DE69736241T2 (en)
ES (1) ES2265653T3 (en)
IL (1) IL127959A0 (en)
IT (1) IT1284867B1 (en)
WO (1) WO1998001149A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288388B1 (en) * 1996-11-19 1998-09-22 Angeletti P Ist Richerche Bio USE OF SUBSTANCES THAT ACTIVATE THE CNTF RECEPTOR (NEUROTROPHIC CHILI FACTOR) FOR THE PREPARATION OF DRUGS FOR THERAPY
IT1291114B1 (en) 1997-03-20 1998-12-29 Angeletti P Ist Richerche Bio VARIATIONS OF THE CHILIARY NEUROTROPHIC FACTOR (CNTF) WITH IMPROVED RECEPTOR SELECTIVITY, AND METHOD FOR THEIR SELECTION
EP3551648A4 (en) * 2016-12-06 2020-07-29 The Board of Trustees of the Leland Stanford Junior University Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same
US11179441B2 (en) 2017-01-06 2021-11-23 The Board Of Trustees Of The Leland Stanford Junior University Ciliary neurotrophic factor receptor ligands and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349056A (en) 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors
WO1995018150A1 (en) * 1993-12-29 1995-07-06 Sumitomo Pharmaceuticals Company, Limited Novel human ciliary neurotrophic factor
GB9413316D0 (en) 1994-07-01 1994-08-24 Cancer Res Campaign Tech Novel proteins

Also Published As

Publication number Publication date
JP2000507271A (en) 2000-06-13
IL127959A0 (en) 1999-11-30
CA2260296A1 (en) 1998-01-15
ES2265653T3 (en) 2007-02-16
EP0936919B1 (en) 2006-06-28
EP0936919A2 (en) 1999-08-25
DE69736241T2 (en) 2007-05-31
AU719086B2 (en) 2000-05-04
US6756357B1 (en) 2004-06-29
WO1998001149A3 (en) 1998-04-23
DE69736241D1 (en) 2006-08-10
ITRM960492A0 (en) 1996-07-10
AU3557697A (en) 1998-02-02
IT1284867B1 (en) 1998-05-22
JP3329826B2 (en) 2002-09-30
ITRM960492A1 (en) 1998-01-10
CA2260296C (en) 2006-05-16
WO1998001149A2 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
LU92780I2 (en) Trastuzumab and recombinant human hyaluronidase
AU2424597A (en) Methods for diagnosing and treating alzheimer's disease
ATE242633T1 (en) DIALKYLFUMARATE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
ATE281840T1 (en) TREATMENT OF DIARRHEA
UY25263A1 (en) 6-DERIVATIVES SUBSTITUTES FOR MYCOPHENOLIC ACID.-
DE59811158D1 (en) USE OF ERYTHROPOIETIN AND IRON PREPARATIONS FOR THE PRODUCTION OF PHARMACEUTICAL COMBINATION PREPARATIONS FOR THE TREATMENT OF RHEUMATIC DISEASES
ATE91628T1 (en) ACID-RESISTANT FIBROBLAST GROWTH FACTOR PREPARATION FOR THE TREATMENT OF GASTROINTESTINAL DISEASES.
ES2133329T3 (en) VARIANTS OF HUMAN IL-3.
NO981136D0 (en) Combined pharmaceutical preparations containing erythropoietin and iron preparations
ATE331734T1 (en) NEUROTROPHIC CILIAR FACTOR WITH ALTERED RANGE OF ACTIVITY COMPARED TO THE WILD-TYPE MOLECULE
NO931413D0 (en) METHODS AND PREPARATIONS FOR TREATMENT OF CELL PROLIFERATION DISEASES
ATE310828T1 (en) IMPLANT AND VECTOR FOR THE TREATMENT OF ACQUIRED DISEASES
ATE345809T1 (en) MEDICINAL COMPOSITION CONTAINING TCF-II
WO1991003226A3 (en) Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
ATE151774T1 (en) CYCLOPENTANPERHYDROPHENANTHRENE-17-BETA-(3-FURYL - 3-DERIVATIVES AND PHARMACEUTICAL PREPARATIONS THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
PT782630E (en) GENE OF THE POLITICAL DISEASE OF RIM
ATE210126T1 (en) 4-AMINO-6-SUBSTITUTED MYCOPHENOLIC ACID DERIVATIVES WITH IMMUNOSUPRESSIVE EFFECTS
ATE293994T1 (en) MULTIVALENT RECOMBINANT ANTIBODIES FOR THE TREATMENT OF HRV INFECTIONS
DK0820507T3 (en) NDF Peptides
UA27055C2 (en) Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of acquired immune deficiency syndrome by the use of this preparation
ATE203680T1 (en) CONJUGATE FOR THE TREATMENT OF INFLAMMATORY DISEASES
IT1251961B (en) PEPTIDES THAT REPRESENT PERMUTATIONS OF THE MASTOPARAN SEQUENCE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties